139 related articles for article (PubMed ID: 22144503)
1. The impact of obesity on follow-up after an abnormal screening mammogram.
Schur EA; Elmore JE; Onega T; Wernli KJ; Sickles EA; Haneuse S
Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):327-36. PubMed ID: 22144503
[TBL] [Abstract][Full Text] [Related]
2. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
[TBL] [Abstract][Full Text] [Related]
3. Timeliness of follow-up after abnormal screening mammogram: variability of facilities.
Rosenberg RD; Haneuse SJ; Geller BM; Buist DS; Miglioretti DL; Brenner RJ; Smith-Bindman R; Taplin SH;
Radiology; 2011 Nov; 261(2):404-13. PubMed ID: 21900620
[TBL] [Abstract][Full Text] [Related]
4. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
Dittus K; Geller B; Weaver DL; Kerlikowske K; Zhu W; Hubbard R; Braithwaite D; O'Meara ES; Miglioretti DL;
J Gen Intern Med; 2013 Nov; 28(11):1454-62. PubMed ID: 23760741
[TBL] [Abstract][Full Text] [Related]
5. Obesity and breast cancer screening.
Wee CC; McCarthy EP; Davis RB; Phillips RS
J Gen Intern Med; 2004 Apr; 19(4):324-31. PubMed ID: 15061741
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.
Hubbard RA; Zhu W; Horblyuk R; Karliner L; Sprague BL; Henderson L; Lee D; Onega T; Buist DS; Sweet A
Breast Cancer Res Treat; 2013 Apr; 138(3):879-87. PubMed ID: 23471650
[TBL] [Abstract][Full Text] [Related]
7. Frequency and Determinants of a Short-Interval Follow-up Recommendation After an Abnormal Screening Mammogram.
Pelletier E; Daigle JM; Defay F; Major D; Guertin MH; Brisson J
Can Assoc Radiol J; 2016 Nov; 67(4):322-329. PubMed ID: 27209218
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
[TBL] [Abstract][Full Text] [Related]
9. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
[TBL] [Abstract][Full Text] [Related]
10. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
[TBL] [Abstract][Full Text] [Related]
11. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram.
Henderson LM; Hubbard RA; Sprague BL; Zhu W; Kerlikowske K
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1882-9. PubMed ID: 26631292
[TBL] [Abstract][Full Text] [Related]
12. Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.
Lawson MB; Bissell MCS; Miglioretti DL; Eavey J; Chapman CH; Mandelblatt JS; Onega T; Henderson LM; Rauscher GH; Kerlikowske K; Sprague BL; Bowles EJA; Gard CC; Parsian S; Lee CI
JAMA Oncol; 2022 Aug; 8(8):1115-1126. PubMed ID: 35737381
[TBL] [Abstract][Full Text] [Related]
13. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
[TBL] [Abstract][Full Text] [Related]
14. Timing of follow-up after abnormal screening and diagnostic mammograms.
Wernli KJ; Aiello Bowles EJ; Haneuse S; Elmore JG; Buist DS
Am J Manag Care; 2011 Feb; 17(2):162-7. PubMed ID: 21473665
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.
White A; Miller J; Royalty J; Ryerson AB; Benard V; Helsel W; Kammerer W
Cancer Causes Control; 2015 May; 26(5):723-32. PubMed ID: 25809209
[TBL] [Abstract][Full Text] [Related]
16. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
17. Rate and Timeliness of Diagnostic Evaluation and Biopsy After Recall From Screening Mammography in the National Mammography Database.
Oluyemi ET; Grimm LJ; Goldman L; Burleson J; Simanowith M; Yao K; Rosenberg RD
J Am Coll Radiol; 2024 Mar; 21(3):427-438. PubMed ID: 37722468
[TBL] [Abstract][Full Text] [Related]
18. Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups.
Nguyen KH; Pasick RJ; Stewart SL; Kerlikowske K; Karliner LS
Cancer; 2017 Sep; 123(18):3468-3475. PubMed ID: 28603859
[TBL] [Abstract][Full Text] [Related]
19. 'Weighing in' on screening mammography.
Berz D; Sikov W; Colvin G; Weitzen S
Breast Cancer Res Treat; 2009 Apr; 114(3):569-74. PubMed ID: 18491226
[TBL] [Abstract][Full Text] [Related]
20. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
